RE-PACT: Respiratory Exacerbation Plans for Action and Care Transitions for Children with Severe CP
RE-PACT:针对严重脑瘫儿童的行动和护理过渡的呼吸加重计划
基本信息
- 批准号:10398191
- 负责人:
- 金额:$ 23.64万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-05-01 至 2024-04-30
- 项目状态:已结题
- 来源:
- 关键词:AccountingAcuteAddressAgeAspiration PneumoniaAsthmaAttentionBehavior TherapyCaliforniaCaregiversCaringCenters for Disease Control and Prevention (U.S.)Cerebral PalsyCessation of lifeChildChild CareChildhoodChronicChronic Obstructive Pulmonary DiseaseClassificationClinicalComplexCustomDataDiagnosisDiseaseEffectivenessEnrollmentEventFamilyFocus GroupsFutureGeographyGoalsHealthHomeHospitalizationHybridsInterventionInterviewKnowledgeLinkMeasuresMediatingMedical Care CostsMeta-AnalysisMethodsModelingMonitorMotivationMotorOutcomeParentsParticipantPatientsPediatric HospitalsPopulationPopulation HeterogeneityPreparationProcessPublic HealthRandomizedRandomized Controlled TrialsReplicating Effective ProgramsReportingRespiratory FailureRiskSamplingSeriesSignal TransductionSpastic TetraplegiaSpecialistSpecific qualifier valueStructureSystemTestingText MessagingTimeWisconsinactive controladaptive interventioncare coordinationcare costsclinical carecomorbiditycongenital heart disordercostdesigndisabilitydisorder controlefficacy trialevidence baseexperienceimprovedimproved outcomeintervention participantsintervention programmHealthmortalityparental monitoringpreventprogramsracial and ethnicrespiratoryresponseroutine caresatisfactionskillssocioeconomicssuccesstool
项目摘要
PROJECT SUMMARY / ABSTRACT
Respiratory illness is the leading cause of hospitalization and death in children with severe cerebral palsy
(CP). Improving these outcomes is limited because interventions to help caregivers identify and manage them
at the right time and context are absent. Severe respiratory illnesses, defined as respiratory diagnoses
requiring hospitalization, begin in the children’s homes, where families are the first in line to manage these
technically challenging and nuanced events. Caregivers report limited knowledge, skill, and confidence to
handle them. To improve these respiratory mortality and hospitalization outcomes, parents need clinical teams
to provide the right support, at the right time, in the right context, i.e., just-in-time and adaptive.
Just-in-time adaptive interventions hold promise to help children with CP with respiratory illness. Our
previously efficacious behavioral intervention gave families of children with complex illnesses, including CP,
action plans and coaching to manage crises; however, plans were pre-specified, static, and did not adjust to
real-time issues. To prevent severe respiratory illness in CP, responses must be dynamic, addressing the
changing contexts and comorbidities that drive these illnesses. Moreover, clinicians and families need simple
tools to signal when attention is most needed, which our mHealth platform was designed to accomplish.
The aims of this application are to (1) refine and adapt the Respiratory Exacerbation Plans for Action and
Care Transitions (RE-PACT) intervention program to severe respiratory illness for children with severe CP
across two clinical programs with racial/ethnic and socioeconomic patient diversity; and (2) establish RE-
PACT’s feasibility, acceptability and effect sizes in preparation for a future fully powered multisite randomized
controlled trial of RE-PACT. We will also conduct exploratory analyses of the mediating influence of changes in
caregiver capability, opportunity and motivation on intervention outcomes to test the theoretical intervention
mechanism. Using the evidence-based Replicating Effective Programs adaptation framework, RE-PACT will
add longitudinal mHealth surveillance of parent confidence to avoid hospitalization, triggering just-in-time
action planning and coaching when confidence of low. Focus groups with target family and clinical teams
caring for children with severe CP, and a national Design and Intervention Strategy expert group will guide
intervention revisions. A sample of 90 caregivers of children with severe CP will then be randomized to receive
RE-PACT or active control. Outcome data will be collected at 6 months using mixed methods to evaluate
intervention: 1) feasibility, 2) acceptability, 3) fidelity, and 4) preliminary efficacy, measured by differences in
severe respiratory illnesses compared to control.
This intervention offers a high potential for widespread dissemination and scalability to address a key
public health problem. Moreover, our long-term goal is to use severe CP as a model, further adapting RE-
PACT to other high-priority conditions relying on families to rapidly handle exacerbations at home.
项目摘要 /摘要
呼吸道疾病是严重脑瘫儿童住院和死亡的主要原因
(CP)。改善这些结果是有限的,因为干预措施可以帮助看护人识别和管理它们
在正确的时间和上下文中,不存在。严重的呼吸道疾病,定义为呼吸诊断
需要住院,从儿童之家开始,那里的家庭是第一个管理这些的家庭
在技术上挑战和细微的事件。看护人报告有限的知识,技能和信心
处理它们。为了改善这些呼吸道死亡率和住院结果,父母需要临床团队
在正确的时间,正确的上下文,即及时和自适应,提供正确的支持。
及时的自适应干预措施有望帮助患有呼吸道疾病的儿童。我们的
以前有效的行为干预使包括CP在内的复杂疾病的儿童家庭
行动计划和管理危机的教练;但是,计划是预先指定的,静态的,并且没有适应
实时问题。为了防止CP严重的呼吸道疾病,反应必须动态,以解决
改变驱动这些疾病的环境和合并症。而且,临床医生和家庭需要简单
最需要注意的工具,我们的MHealth平台旨在实现这一目标。
本申请的目的是(1)完善和适应呼吸加剧计划的行动和
患有严重CP儿童的严重呼吸系统疾病的护理过渡(重新条纹)干预计划
在两个具有种族/种族和社会经济患者多样性的临床计划中; (2)建立重新
PACT的可行性,可接受性和效果大小,以准备将来完全有能力的多站点随机分组
对照试验的重新pact试验。我们还将对变化的中介影响进行探索性分析
护理人员的能力,机会和动力进行干预结果测试理论干预
机制。使用基于循证的复制有效程序适应框架,重新pact将
添加对父母信心的纵向MHealth监视以避免住院,触发即时
当信心低时,行动计划和教练。与目标家庭和临床团队的焦点小组
照顾患有严重CP的儿童以及国家设计和干预策略专家小组将指导
干预修订。然后将有90名严重CP儿童的护理人员随机分配
重新pact或主动控制。结果数据将在6个月的时间使用混合方法来收集
干预:1)可行性,2)可接受性,3)保真度和4)初步效率,以差异为衡量
与对照相比,严重的呼吸道疾病。
这种干预措施为宽度传播和可扩展性提供了很高的潜力
公共卫生问题。此外,我们的长期目标是将严重的CP用作模型,进一步适应重新调整
依靠家庭在家中快速处理加剧的其他高优先级条件的协议。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ryan J Coller其他文献
Linking Parent Confidence and Hospitalization through mHealth: A Multisite Pilot Study.
通过移动医疗将家长信心与住院联系起来:多地点试点研究。
- DOI:
- 发表时间:
2020 - 期刊:
- 影响因子:3.3
- 作者:
Ryan J Coller;Carlos F. Lerner;J. Berry;T. Klitzner;Carolyn Allshouse;Gemma Warner;Carrie L. Nacht;Lindsey R. Thompson;J. Eickhoff;Mary Ehlenbach;Andrea J Bonilla;Melanie Venegas;Brigid M. Garrity;Elizabeth L Casto;T. Bowe;P. Chung - 通讯作者:
P. Chung
Growing Evidence for Successful Care Management in Children With Medical Complexity
越来越多的证据表明医疗复杂性儿童的成功护理管理
- DOI:
10.1542/peds.2019-3982 - 发表时间:
2020 - 期刊:
- 影响因子:8
- 作者:
Mary Ehlenbach;Ryan J Coller - 通讯作者:
Ryan J Coller
Preventing Emergency Department Visits for Children with Medical Complexity through Ambulatory Care: A Systematic Review.
通过门诊护理防止患有医疗复杂性的儿童去急诊室就诊:系统回顾。
- DOI:
- 发表时间:
2021 - 期刊:
- 影响因子:3.1
- 作者:
C. Pulcini;Ryan J Coller;A. Houtrow;Zoe Belardo;J. Zorc - 通讯作者:
J. Zorc
Standardizing Medical Complexity: Fruitful, Formidable, or Futile?
标准化医疗复杂性:富有成效、令人敬畏还是徒劳?
- DOI:
- 发表时间:
2024 - 期刊:
- 影响因子:8
- 作者:
Danielle Gerber;Ryan J Coller - 通讯作者:
Ryan J Coller
Identifying Tools and Technology Barriers to In-Home Care for Children with Medical Complexity
确定医疗复杂性儿童家庭护理的工具和技术障碍
- DOI:
- 发表时间:
2021 - 期刊:
- 影响因子:0
- 作者:
Reid Parks;Nadia Doutcheva;Dhivya Umachandran;Nawang Singhe;Sofia Noejovich;Mary Ehlenbach;Gemma Warner;Carrie L. Nacht;Michelle M. Kelly;Ryan J Coller;N. Werner - 通讯作者:
N. Werner
Ryan J Coller的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ryan J Coller', 18)}}的其他基金
Improving medication safety for medically complex children with mHealth across caregiving networks
通过跨护理网络的移动医疗提高病情复杂的儿童的用药安全
- 批准号:
10411594 - 财政年份:2022
- 资助金额:
$ 23.64万 - 项目类别:
Improving medication safety for medically complex children with mHealth across caregiving networks
通过跨护理网络的移动医疗提高病情复杂的儿童的用药安全
- 批准号:
10616759 - 财政年份:2022
- 资助金额:
$ 23.64万 - 项目类别:
RE-PACT: Respiratory Exacerbation Plans for Action and Care Transitions for Children with Severe CP
RE-PACT:针对严重脑瘫儿童的行动和护理过渡的呼吸加重计划
- 批准号:
10218770 - 财政年份:2021
- 资助金额:
$ 23.64万 - 项目类别:
RE-PACT: Respiratory Exacerbation Plans for Action and Care Transitions for Children with Severe CP
RE-PACT:针对严重脑瘫儿童的行动和护理过渡的呼吸加重计划
- 批准号:
10625829 - 财政年份:2021
- 资助金额:
$ 23.64万 - 项目类别:
ReSET: Restarting Safe Education and Testing for Children with Medical Complexity
ReSET:为患有医疗复杂性的儿童重新启动安全教育和测试
- 批准号:
10371691 - 财政年份:2021
- 资助金额:
$ 23.64万 - 项目类别:
ReSET: Restarting Safe Education and Testing for Children with Medical Complexity
ReSET:为患有医疗复杂性的儿童重新启动安全教育和测试
- 批准号:
10557393 - 财政年份:2021
- 资助金额:
$ 23.64万 - 项目类别:
相似国自然基金
用于急性出血控制的硅酸钙复合海绵的构建及其促凝血性能和机制研究
- 批准号:32301097
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
AF9通过ARRB2-MRGPRB2介导肠固有肥大细胞活化促进重症急性胰腺炎发生MOF的研究
- 批准号:82300739
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
代谢工程化MSC胞外囊泡靶向调控巨噬细胞线粒体动力学改善急性肾损伤的作用及机制研究
- 批准号:32371426
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
DUSP2介导自噬调控气管上皮细胞炎症在急性肺损伤中的机制研究
- 批准号:82360379
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
超声射频信号神经回路策略模型定量肌肉脂肪化评估慢加急性肝衰竭预后
- 批准号:82302221
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Climate Change Effects on Pregnancy via a Traditional Food
气候变化通过传统食物对怀孕的影响
- 批准号:
10822202 - 财政年份:2024
- 资助金额:
$ 23.64万 - 项目类别:
Determining medications associated with drug-induced pancreatic injury through novel pharmacoepidemiology techniques that assess causation
通过评估因果关系的新型药物流行病学技术确定与药物引起的胰腺损伤相关的药物
- 批准号:
10638247 - 财政年份:2023
- 资助金额:
$ 23.64万 - 项目类别:
TIER-PALLIATIVE CARE: A population-based care delivery model to match evolving patient needs and palliative care services for community-based patients with heart failure or cancer
分级姑息治疗:基于人群的护理提供模式,以满足不断变化的患者需求,并为社区心力衰竭或癌症患者提供姑息治疗服务
- 批准号:
10880994 - 财政年份:2023
- 资助金额:
$ 23.64万 - 项目类别:
Identification of gene variants mediating the behavioral and physiological response to THC
鉴定介导 THC 行为和生理反应的基因变异
- 批准号:
10660808 - 财政年份:2023
- 资助金额:
$ 23.64万 - 项目类别: